Suppr超能文献

大脑中动脉大面积梗死的去骨瓣减压术与保守治疗:一项综述及荟萃分析

Hemicraniectomy versus medical treatment with large MCA infarct: a review and meta-analysis.

作者信息

Alexander Paul, Heels-Ansdell Diane, Siemieniuk Reed, Bhatnagar Neera, Chang Yaping, Fei Yutong, Zhang Yuqing, McLeod Shelley, Prasad Kameshwar, Guyatt Gordon

机构信息

Department of Clinical Epidemiology and Biostatistics, Health Research Methods, McMaster University, Hamilton, Ontario, Canada.

Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.

出版信息

BMJ Open. 2016 Nov 24;6(11):e014390. doi: 10.1136/bmjopen-2016-014390.

Abstract

OBJECTIVE

Large middle cerebral artery stroke (space-occupying middle-cerebral-artery (MCA) infarction (SO-MCAi)) results in a very high incidence of death and severe disability. Decompressive hemicraniectomy (DHC) for SO-MCAi results in large reductions in mortality; the level of function in the survivors, and implications, remain controversial. To address the controversy, we pooled available randomised controlled trials (RCTs) that examined the impact of DHC on survival and functional ability in patients with large SO-MCAi and cerebral oedema.

METHODS

We searched MEDLINE, EMBASE and Cochrane library databases for randomised controlled trials (RCTs) enrolling patients suffering SO-MCAi comparing conservative management to DHC administered within 96 hours after stroke symptom onset. Outcomes were death and disability measured by the modified Rankin Scale (mRS). We used a random effects meta-analytical approach with subgroup analyses (time to treatment and age). We applied GRADE methods to rate quality/confidence/certainty of evidence.

RESULTS

7 RCTs were eligible (n=338 patients). We found DHC reduced death (69-30% in medical vs surgical groups, 39% fewer), and increased the number of patients with mRS of 2-3 (slight to moderate disability: 14-27%, increase of 13%), those with mRS 4 (severe disability: 10-32%, increase of 22%) and those with mRS 5 (very severe disability 7-11%: increase of 4%) (all differences p<0.0001). We judged quality/confidence/certainty of evidence high for death, low for functional outcome mRS 0-3, and moderate for mRS 0-4 (wide CIs and problems in concealment, blinding of outcome assessors and stopping early).

CONCLUSIONS

DHC in SO-MCAi results in large reductions in mortality. Most of those who would otherwise have died are left with severe or very severe disability: for example, inability to walk and a requirement for help with bodily needs, though uncertainty about the proportion with very severe, severe and moderate disability remains (low to moderate quality/confidence/certainty evidence).

摘要

目的

大脑中动脉大面积卒中(占位性大脑中动脉梗死(SO-MCAi))导致极高的死亡率和严重残疾率。针对SO-MCAi进行的去骨瓣减压术(DHC)可大幅降低死亡率;但幸存者的功能水平及其影响仍存在争议。为解决这一争议,我们汇总了现有的随机对照试验(RCT),这些试验研究了DHC对患有大面积SO-MCAi和脑水肿患者的生存及功能能力的影响。

方法

我们在MEDLINE、EMBASE和Cochrane图书馆数据库中检索随机对照试验(RCT),纳入患有SO-MCAi的患者,比较保守治疗与卒中症状发作后96小时内进行DHC的疗效。结局指标为改良Rankin量表(mRS)测量的死亡和残疾情况。我们采用随机效应荟萃分析方法及亚组分析(治疗时间和年龄)。我们应用GRADE方法对证据的质量/可信度/确定性进行评级。

结果

7项RCT符合条件(n = 338例患者)。我们发现DHC降低了死亡率(药物治疗组与手术治疗组分别为69%和30%,减少了39%),并增加了mRS评分为2 - 3分(轻度至中度残疾:14% - 27%,增加了13%)、mRS 4分(重度残疾:10% - 32%,增加了22%)和mRS 5分(极重度残疾7% - 11%:增加了4%)的患者数量(所有差异p < 0.0001)。我们判断死亡证据的质量/可信度/确定性为高,功能结局mRS 0 - 3的为低,mRS 0 - 4的为中等(置信区间宽,存在分配隐藏、结局评估者盲法及提前终止试验方面的问题)。

结论

SO-MCAi患者进行DHC可大幅降低死亡率。大多数原本会死亡的患者会遗留重度或极重度残疾:例如,无法行走且在身体需求方面需要他人帮助,不过重度、极重度和中度残疾患者的比例仍存在不确定性(低至中等质量/可信度/确定性证据)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a8/5168488/96473370aa44/bmjopen2016014390f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验